BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26299766)

  • 1. Targeting Mycobacterium tuberculosis Biotin Protein Ligase (MtBPL) with Nucleoside-Based Bisubstrate Adenylation Inhibitors.
    Bockman MR; Kalinda AS; Petrelli R; De la Mora-Rey T; Tiwari D; Liu F; Dawadi S; Nandakumar M; Rhee KY; Schnappinger D; Finzel BC; Aldrich CC
    J Med Chem; 2015 Sep; 58(18):7349-7369. PubMed ID: 26299766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisubstrate adenylation inhibitors of biotin protein ligase from Mycobacterium tuberculosis.
    Duckworth BP; Geders TW; Tiwari D; Boshoff HI; Sibbald PA; Barry CE; Schnappinger D; Finzel BC; Aldrich CC
    Chem Biol; 2011 Nov; 18(11):1432-41. PubMed ID: 22118677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoiding Antibiotic Inactivation in Mycobacterium tuberculosis by Rv3406 through Strategic Nucleoside Modification.
    Bockman MR; Engelhart CA; Dawadi S; Larson P; Tiwari D; Ferguson DM; Schnappinger D; Aldrich CC
    ACS Infect Dis; 2018 Jul; 4(7):1102-1113. PubMed ID: 29663798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitubercular nucleosides that inhibit siderophore biosynthesis: SAR of the glycosyl domain.
    Somu RV; Wilson DJ; Bennett EM; Boshoff HI; Celia L; Beck BJ; Barry CE; Aldrich CC
    J Med Chem; 2006 Dec; 49(26):7623-35. PubMed ID: 17181146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity in functional organization of class I and class II biotin protein ligase.
    Purushothaman S; Annamalai K; Tyagi AK; Surolia A
    PLoS One; 2011 Mar; 6(3):e16850. PubMed ID: 21390227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisubstrate Inhibitors of Biotin Protein Ligase in
    Shi C; Tiwari D; Wilson DJ; Seiler CL; Schnappinger D; Aldrich CC
    ACS Med Chem Lett; 2013 Dec; 4(12):1213-7. PubMed ID: 24363833
    [No Abstract]   [Full Text] [Related]  

  • 7. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
    Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
    ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis.
    Baran M; Grimes KD; Sibbald PA; Fu P; Boshoff HIM; Wilson DJ; Aldrich CC
    Eur J Med Chem; 2020 Sep; 201():112408. PubMed ID: 32574901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of
    Schumann NC; Lee KJ; Thompson AP; Salaemae W; Pederick JL; Avery T; Gaiser BI; Hodgkinson-Bean J; Booker GW; Polyak SW; Bruning JB; Wegener KL; Abell AD
    ACS Chem Biol; 2021 Nov; 16(11):2339-2347. PubMed ID: 34533923
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism-based inactivation by aromatization of the transaminase BioA involved in biotin biosynthesis in Mycobaterium tuberculosis.
    Shi C; Geders TW; Park SW; Wilson DJ; Boshoff HI; Abayomi O; Barry CE; Schnappinger D; Finzel BC; Aldrich CC
    J Am Chem Soc; 2011 Nov; 133(45):18194-201. PubMed ID: 21988601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis.
    Engelhart CA; Aldrich CC
    J Org Chem; 2013 Aug; 78(15):7470-81. PubMed ID: 23805993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Mycobacterium tuberculosis CtpF as a target for designing new antituberculous compounds.
    Santos P; Lopez-Vallejo F; Ramírez D; Caballero J; Mata Espinosa D; Hernández-Pando R; Soto CY
    Bioorg Med Chem; 2020 Feb; 28(3):115256. PubMed ID: 31879181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-(1-Arylethylpiperidin-4-yl)thymine Analogs as Antimycobacterial TMPK Inhibitors.
    Jian Y; Hulpia F; D P Risseeuw M; Forbes HE; Caljon G; Munier-Lehmann H; I M Boshoff H; Van Calenbergh S
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32560578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.
    Zhang W; Liu LL; Lun S; Wang SS; Xiao S; Gunosewoyo H; Yang F; Tang J; Bishai WR; Yu LF
    Eur J Med Chem; 2021 Mar; 213():113202. PubMed ID: 33516983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan H; Doğan ŞD; Gündüz MG; Krishna VS; Lherbet C; Sriram D; Şahin O; Sarıpınar E
    Eur J Med Chem; 2020 Feb; 188():112035. PubMed ID: 31951850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target-based identification of whole-cell active inhibitors of biotin biosynthesis in Mycobacterium tuberculosis.
    Park SW; Casalena DE; Wilson DJ; Dai R; Nag PP; Liu F; Boyce JP; Bittker JA; Schreiber SL; Finzel BC; Schnappinger D; Aldrich CC
    Chem Biol; 2015 Jan; 22(1):76-86. PubMed ID: 25556942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand specificity of group I biotin protein ligase of Mycobacterium tuberculosis.
    Purushothaman S; Gupta G; Srivastava R; Ramu VG; Surolia A
    PLoS One; 2008 May; 3(5):e2320. PubMed ID: 18509457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
    Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Nov; 22(21):6134-45. PubMed ID: 25282650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Activity Relationships of the MEPicides: N-Acyl and O-Linked Analogs of FR900098 as Inhibitors of Dxr from Mycobacterium tuberculosis and Yersinia pestis.
    San Jose G; Jackson ER; Haymond A; Johny C; Edwards RL; Wang X; Brothers RC; Edelstein EK; Odom AR; Boshoff HI; Couch RD; Dowd CS
    ACS Infect Dis; 2016 Dec; 2(12):923-935. PubMed ID: 27676224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis.
    He X; Alian A; Stroud R; Ortiz de Montellano PR
    J Med Chem; 2006 Oct; 49(21):6308-23. PubMed ID: 17034137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.